Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Cancer Vaccines. This report contains market size and forecasts of Therapeutic Cancer Vaccines in global, including the following market information:
Global Therapeutic Cancer Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Therapeutic Cancer Vaccines Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Therapeutic Cancer Vaccines companies in 2022 (%)
The global Therapeutic Cancer Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Whole Cell Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Cancer Vaccines include Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna and Northwest Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Therapeutic Cancer Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Cancer Vaccines Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Therapeutic Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
Whole Cell Vaccine
Antigen Vaccine
Non-specific and Cytokine Strategies
Others
Global Therapeutic Cancer Vaccines Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Therapeutic Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
Bladder Cancer
Brain Tumors
Breast Cancer
Lung Cancer
Prostate Cancer
Cervical Cancer
Others
Global Therapeutic Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Therapeutic Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Cancer Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Therapeutic Cancer Vaccines revenues share in global market, 2022 (%)
Key companies Therapeutic Cancer Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Therapeutic Cancer Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Antigenics
Asterias Biotherapeutics
Avax Technologies
Bayer
GlaxoSmithKline
Mayo Clinic
Merck
Moderna
Northwest Biotherapeutics
VAXIMM
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Cancer Vaccines, market overview.
Chapter 2: Global Therapeutic Cancer Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Therapeutic Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Therapeutic Cancer Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Cancer Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Cancer Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Cancer Vaccines Overall Market Size
2.1 Global Therapeutic Cancer Vaccines Market Size: 2022 VS 2030
2.2 Global Therapeutic Cancer Vaccines Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Therapeutic Cancer Vaccines Sales: 2018-2030
3 Company Landscape
3.1 Top Therapeutic Cancer Vaccines Players in Global Market
3.2 Top Global Therapeutic Cancer Vaccines Companies Ranked by Revenue
3.3 Global Therapeutic Cancer Vaccines Revenue by Companies
3.4 Global Therapeutic Cancer Vaccines Sales by Companies
3.5 Global Therapeutic Cancer Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Therapeutic Cancer Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Therapeutic Cancer Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Therapeutic Cancer Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Therapeutic Cancer Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Therapeutic Cancer Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Cancer Vaccines Market Size Markets, 2022 & 2030
4.1.2 Whole Cell Vaccine
4.1.3 Antigen Vaccine
4.1.4 Non-specific and Cytokine Strategies
4.1.5 Others
4.2 By Type - Global Therapeutic Cancer Vaccines Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Cancer Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Therapeutic Cancer Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
4.3 By Type - Global Therapeutic Cancer Vaccines Sales & Forecasts
4.3.1 By Type - Global Therapeutic Cancer Vaccines Sales, 2018-2023
4.3.2 By Type - Global Therapeutic Cancer Vaccines Sales, 2024-2030
4.3.3 By Type - Global Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
4.4 By Type - Global Therapeutic Cancer Vaccines Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Cancer Vaccines Market Size, 2022 & 2030
5.1.2 Bladder Cancer
5.1.3 Brain Tumors
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Prostate Cancer
5.1.7 Cervical Cancer
5.1.8 Others
5.2 By Application - Global Therapeutic Cancer Vaccines Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Cancer Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Therapeutic Cancer Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
5.3 By Application - Global Therapeutic Cancer Vaccines Sales & Forecasts
5.3.1 By Application - Global Therapeutic Cancer Vaccines Sales, 2018-2023
5.3.2 By Application - Global Therapeutic Cancer Vaccines Sales, 2024-2030
5.3.3 By Application - Global Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
5.4 By Application - Global Therapeutic Cancer Vaccines Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Therapeutic Cancer Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Therapeutic Cancer Vaccines Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Cancer Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Therapeutic Cancer Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
6.3 By Region - Global Therapeutic Cancer Vaccines Sales & Forecasts
6.3.1 By Region - Global Therapeutic Cancer Vaccines Sales, 2018-2023
6.3.2 By Region - Global Therapeutic Cancer Vaccines Sales, 2024-2030
6.3.3 By Region - Global Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Therapeutic Cancer Vaccines Revenue, 2018-2030
6.4.2 By Country - North America Therapeutic Cancer Vaccines Sales, 2018-2030
6.4.3 US Therapeutic Cancer Vaccines Market Size, 2018-2030
6.4.4 Canada Therapeutic Cancer Vaccines Market Size, 2018-2030
6.4.5 Mexico Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Therapeutic Cancer Vaccines Revenue, 2018-2030
6.5.2 By Country - Europe Therapeutic Cancer Vaccines Sales, 2018-2030
6.5.3 Germany Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5.4 France Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5.5 U.K. Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5.6 Italy Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5.7 Russia Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5.8 Nordic Countries Therapeutic Cancer Vaccines Market Size, 2018-2030
6.5.9 Benelux Therapeutic Cancer Vaccines Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Therapeutic Cancer Vaccines Revenue, 2018-2030
6.6.2 By Region - Asia Therapeutic Cancer Vaccines Sales, 2018-2030
6.6.3 China Therapeutic Cancer Vaccines Market Size, 2018-2030
6.6.4 Japan Therapeutic Cancer Vaccines Market Size, 2018-2030
6.6.5 South Korea Therapeutic Cancer Vaccines Market Size, 2018-2030
6.6.6 Southeast Asia Therapeutic Cancer Vaccines Market Size, 2018-2030
6.6.7 India Therapeutic Cancer Vaccines Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Therapeutic Cancer Vaccines Revenue, 2018-2030
6.7.2 By Country - South America Therapeutic Cancer Vaccines Sales, 2018-2030
6.7.3 Brazil Therapeutic Cancer Vaccines Market Size, 2018-2030
6.7.4 Argentina Therapeutic Cancer Vaccines Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Therapeutic Cancer Vaccines Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Therapeutic Cancer Vaccines Sales, 2018-2030
6.8.3 Turkey Therapeutic Cancer Vaccines Market Size, 2018-2030
6.8.4 Israel Therapeutic Cancer Vaccines Market Size, 2018-2030
6.8.5 Saudi Arabia Therapeutic Cancer Vaccines Market Size, 2018-2030
6.8.6 UAE Therapeutic Cancer Vaccines Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Antigenics
7.1.1 Antigenics Company Summary
7.1.2 Antigenics Business Overview
7.1.3 Antigenics Therapeutic Cancer Vaccines Major Product Offerings
7.1.4 Antigenics Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Antigenics Key News & Latest Developments
7.2 Asterias Biotherapeutics
7.2.1 Asterias Biotherapeutics Company Summary
7.2.2 Asterias Biotherapeutics Business Overview
7.2.3 Asterias Biotherapeutics Therapeutic Cancer Vaccines Major Product Offerings
7.2.4 Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Asterias Biotherapeutics Key News & Latest Developments
7.3 Avax Technologies
7.3.1 Avax Technologies Company Summary
7.3.2 Avax Technologies Business Overview
7.3.3 Avax Technologies Therapeutic Cancer Vaccines Major Product Offerings
7.3.4 Avax Technologies Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Avax Technologies Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Therapeutic Cancer Vaccines Major Product Offerings
7.4.4 Bayer Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Therapeutic Cancer Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Mayo Clinic
7.6.1 Mayo Clinic Company Summary
7.6.2 Mayo Clinic Business Overview
7.6.3 Mayo Clinic Therapeutic Cancer Vaccines Major Product Offerings
7.6.4 Mayo Clinic Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Mayo Clinic Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Therapeutic Cancer Vaccines Major Product Offerings
7.7.4 Merck Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Moderna
7.8.1 Moderna Company Summary
7.8.2 Moderna Business Overview
7.8.3 Moderna Therapeutic Cancer Vaccines Major Product Offerings
7.8.4 Moderna Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Moderna Key News & Latest Developments
7.9 Northwest Biotherapeutics
7.9.1 Northwest Biotherapeutics Company Summary
7.9.2 Northwest Biotherapeutics Business Overview
7.9.3 Northwest Biotherapeutics Therapeutic Cancer Vaccines Major Product Offerings
7.9.4 Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Northwest Biotherapeutics Key News & Latest Developments
7.10 VAXIMM
7.10.1 VAXIMM Company Summary
7.10.2 VAXIMM Business Overview
7.10.3 VAXIMM Therapeutic Cancer Vaccines Major Product Offerings
7.10.4 VAXIMM Therapeutic Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 VAXIMM Key News & Latest Developments
8 Global Therapeutic Cancer Vaccines Production Capacity, Analysis
8.1 Global Therapeutic Cancer Vaccines Production Capacity, 2018-2030
8.2 Therapeutic Cancer Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Therapeutic Cancer Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Therapeutic Cancer Vaccines Supply Chain Analysis
10.1 Therapeutic Cancer Vaccines Industry Value Chain
10.2 Therapeutic Cancer Vaccines Upstream Market
10.3 Therapeutic Cancer Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Therapeutic Cancer Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Therapeutic Cancer Vaccines in Global Market
Table 2. Top Therapeutic Cancer Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Therapeutic Cancer Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Therapeutic Cancer Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Therapeutic Cancer Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Therapeutic Cancer Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Therapeutic Cancer Vaccines Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Therapeutic Cancer Vaccines Product Type
Table 9. List of Global Tier 1 Therapeutic Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Therapeutic Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Therapeutic Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Therapeutic Cancer Vaccines Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Therapeutic Cancer Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Therapeutic Cancer Vaccines Sales (K Units), 2024-2030
Table 16. By Application ? Global Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Therapeutic Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Therapeutic Cancer Vaccines Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Therapeutic Cancer Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Therapeutic Cancer Vaccines Sales (K Units), 2024-2030
Table 21. By Region ? Global Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Therapeutic Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Therapeutic Cancer Vaccines Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Therapeutic Cancer Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Therapeutic Cancer Vaccines Sales (K Units), 2024-2030
Table 26. By Country - North America Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Therapeutic Cancer Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Therapeutic Cancer Vaccines Sales, (K Units), 2024-2030
Table 30. By Country - Europe Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Therapeutic Cancer Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Therapeutic Cancer Vaccines Sales, (K Units), 2024-2030
Table 34. By Region - Asia Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Therapeutic Cancer Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Therapeutic Cancer Vaccines Sales, (K Units), 2024-2030
Table 38. By Country - South America Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Therapeutic Cancer Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Therapeutic Cancer Vaccines Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Therapeutic Cancer Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Therapeutic Cancer Vaccines Sales, (K Units), 2024-2030
Table 46. Antigenics Company Summary
Table 47. Antigenics Therapeutic Cancer Vaccines Product Offerings
Table 48. Antigenics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Antigenics Key News & Latest Developments
Table 50. Asterias Biotherapeutics Company Summary
Table 51. Asterias Biotherapeutics Therapeutic Cancer Vaccines Product Offerings
Table 52. Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Asterias Biotherapeutics Key News & Latest Developments
Table 54. Avax Technologies Company Summary
Table 55. Avax Technologies Therapeutic Cancer Vaccines Product Offerings
Table 56. Avax Technologies Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Avax Technologies Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Therapeutic Cancer Vaccines Product Offerings
Table 60. Bayer Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Therapeutic Cancer Vaccines Product Offerings
Table 64. GlaxoSmithKline Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Mayo Clinic Company Summary
Table 67. Mayo Clinic Therapeutic Cancer Vaccines Product Offerings
Table 68. Mayo Clinic Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Mayo Clinic Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Therapeutic Cancer Vaccines Product Offerings
Table 72. Merck Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Moderna Company Summary
Table 75. Moderna Therapeutic Cancer Vaccines Product Offerings
Table 76. Moderna Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Moderna Key News & Latest Developments
Table 78. Northwest Biotherapeutics Company Summary
Table 79. Northwest Biotherapeutics Therapeutic Cancer Vaccines Product Offerings
Table 80. Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Northwest Biotherapeutics Key News & Latest Developments
Table 82. VAXIMM Company Summary
Table 83. VAXIMM Therapeutic Cancer Vaccines Product Offerings
Table 84. VAXIMM Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. VAXIMM Key News & Latest Developments
Table 86. Therapeutic Cancer Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Therapeutic Cancer Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Therapeutic Cancer Vaccines Production by Region, 2018-2023 (K Units)
Table 89. Global Therapeutic Cancer Vaccines Production by Region, 2024-2030 (K Units)
Table 90. Therapeutic Cancer Vaccines Market Opportunities & Trends in Global Market
Table 91. Therapeutic Cancer Vaccines Market Drivers in Global Market
Table 92. Therapeutic Cancer Vaccines Market Restraints in Global Market
Table 93. Therapeutic Cancer Vaccines Raw Materials
Table 94. Therapeutic Cancer Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Therapeutic Cancer Vaccines Downstream
Table 96. Therapeutic Cancer Vaccines Downstream Clients in Global Market
Table 97. Therapeutic Cancer Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Therapeutic Cancer Vaccines Segment by Type in 2022
Figure 2. Therapeutic Cancer Vaccines Segment by Application in 2022
Figure 3. Global Therapeutic Cancer Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Therapeutic Cancer Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Therapeutic Cancer Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. Therapeutic Cancer Vaccines Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Therapeutic Cancer Vaccines Revenue in 2022
Figure 9. By Type - Global Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 11. By Type - Global Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 12. By Type - Global Therapeutic Cancer Vaccines Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 15. By Application - Global Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 16. By Application - Global Therapeutic Cancer Vaccines Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 20. By Region - Global Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 21. By Country - North America Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 22. By Country - North America Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 23. US Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 28. Germany Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. France Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 37. China Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. India Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 43. By Country - South America Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 44. Brazil Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Therapeutic Cancer Vaccines Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Therapeutic Cancer Vaccines Sales Market Share, 2018-2030
Figure 48. Turkey Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Therapeutic Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 52. Global Therapeutic Cancer Vaccines Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Therapeutic Cancer Vaccines by Region, 2022 VS 2030
Figure 54. Therapeutic Cancer Vaccines Industry Value Chain
Figure 55. Marketing Channels
